A home-grown leader in sleep and neural analysis, Compumedics is tackling the burgeoning US home sleep testing market.

The PlayStation 5 consoles are made in China, which remain subject to Mr Trump’s bruising tariffs, with Beijing and the White ...

It's a subdued start to trading with tariff talk dampening US markets. Pharmaceutical and Energy stocks are the unlucky casualties today.

HyTerra (ASX:HYT) is ready to start drilling at its Nemaha project in Kansas, USA aiming tounlock the white hydrogen potential.

Blue Star Helium (ASX:BNL) continues drilling for lofty helium success at the Galactica project as demand for the rare gas rises.

Norwest Minerals (ASX:NWM) is looking to carry out more drilling and identify further gold resources after securing the Bulgera mining lease.

Guy Le Page looks at Cygnus Metals and its big plans to build out a high-grade copper-gold opportunity through additional discoveries.

QMines (ASX:QML) is consolidating its footprint with a new gold-silver opportunity at Mount Mackenzie in Queensland.

Canaccord's Tim Hoff saw Azure Minerals coming before it happened. He thinks Zambian copper junior Prospect has similar credentials.

Strength in healthcare and financial stocks has kept the ASX on life support, retaining some gains to lift 0.21pc overall.

Neuren Pharmaceuticals and its US partner Acadia have been blitzing it with the Rett syndrome treatment Daybue.

Meteoric Resources has been up to 36.3% higher after releasing a maiden resource estimate for the Bara do Pacu licence at its Caldeira REE project in Brazil.